NCT05294081

Brief Summary

The overall aim of the present study is to compare two different psychological methods, Cognitive Behavioural Therapy (CBT) and Graduated Exposure in vivo (EXP) in the treatment of chronic back pain with regard to effectiveness and improvement of pain related disability. Exploratory research will also be conducted to identify predictors of which patient groups benefit more from which method. This should optimise treatment options and create effective treatment offers for subgroups of pain patients. Exposure therapy is an effective and economical treatment modality and was shown in a previous pilot study to be superior to CBT in reducing perceived movement limitation. CBT, on the other hand, appeared to be more effective in establishing coping strategies. With the help of the current study it should be possible to compare the effectiveness of both treatment methods and, in perspective, to identify those patient groups that benefit from exposure therapy and thus create a tailor-made treatment programme for subgroups of pain patients. A total of 380 patients (age: ≥ 18) with chronic back pain and a sufficient degree of impairment will be included and analysed in the study.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
380

participants targeted

Target at P75+ for not_applicable

Timeline
18mo left

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

5 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Mar 2022Oct 2027

Study Start

First participant enrolled

March 1, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

March 2, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

March 24, 2022

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2027

Expected
Last Updated

May 20, 2025

Status Verified

May 1, 2025

Enrollment Period

3.7 years

First QC Date

March 2, 2022

Last Update Submit

May 14, 2025

Conditions

Keywords

Chronic Low Back PainCognitive Behavioural TherapyExposureFear AvoidanceCognitive Behavioural Therapy in chronic low back painExposure in vivo in chronic low back pain

Outcome Measures

Primary Outcomes (1)

  • Change in pain related disability

    Clinically significant change in pain-related impairment at the end of therapy and at 6-months and 2-years follow-up compared to baseline. Quebec Back Pain Disability Scale (QBPDS). Each item is scored from 0 to 5 (0 = not difficult at all, 5 = unable to do). Higher total scores reflect higher disability.

    from Baseline to Posttest (an expected average of 15 weeks) to Follow Up Assessments (an expected average of 6 months after Posttest and 2 years after Posttest)

Secondary Outcomes (8)

  • Change in pain disability

    from Baseline to Posttest (an expected average of 15 weeks) to Follow Up Assessments (an expected average of 6 months and 2 years after Posttest)

  • Change in pain intensity

    from Baseline to Posttest (an expected average of 15 weeks) to Follow Up Assessments (an expected average of 6 months and 2 years after Posttest)

  • Change in coping

    from Baseline to Posttest (an expected average of 15 weeks) to Follow Up Assessments (an expected average of 6 months and 2 years after Posttest)

  • Change in emotional distress

    from Baseline to Posttest (an expected average of 15 weeks) to Follow Up Assessments (an expected average of 6 months and 2 years after Posttest)

  • Change in pain catastrophizing

    from Baseline to Posttest (an expected average of 15 weeks) to Follow Up Assessments (an expected average of 6 months and 2 years after Posttest)

  • +3 more secondary outcomes

Study Arms (2)

Exposure (EXP)

EXPERIMENTAL

Exposure in vivo for fear avoidant chronic low back pain patients. This treatment means that the individual is exposed to movements and tasks that have been avoided due to fear of (re)injury. The treatment begins after three educational lessons including the rational and developing a fear hierarchy. Exposure phase includes 10 exposures sessions which are highly individualized. Behavioral experiments can be included to correct catastrophic misinterpretations. The main purpose of this intervention type is to reduce pain related disability via diminishing fear avoidance.

Behavioral: Exposure therapy

Cognitive Behavioural Therapy (CBT)

ACTIVE COMPARATOR

Cognitive behavioural psychotherapy for fear avoidant chronic low back patients. The therapy is modularized in three main parts. The educational lesson is followed by the module graded activity which represents the behavioral part of the program. The second module comprises relaxation. And the last part contains cognitive interventions. Cognitive behavioural intervention techniques are employed to support the patient in the process of coping with chronic pain: i.e. reduction of disability and improving functional ability.

Behavioral: Cognitive behavioral therapy

Interventions

10 sessions based on an individualized pain hierarchy

Exposure (EXP)

10 sessions with graded activity, relaxations techniques and cognitive interventions

Cognitive Behavioural Therapy (CBT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic low back pain (duration \> 6 months, pain on most days of the week)
  • Sufficient level of disability, as defined by QBPDS ≥ 15 (Quebec Back Pain Disability Scale)
  • Age 18 and above
  • Agreeing to participate, verified by completion of informed consent

You may not qualify if:

  • Back surgeries during the last six months or planned surgeries
  • Red Flags
  • inability to read or write in German
  • pregnancy
  • severe alcohol or drug addiction
  • psychotic disorders
  • another current psychological treatment
  • physical inability to attend sessions
  • parallel participation in another intervention study
  • Depression will be controlled for, medication will be required to stay stable until Follow-up and any changes will be controlled for, on-demand ("rescue") medication will be not allowed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

RPTU Kaiserslautern- Landau

Landau, RLP, 76829, Germany

Location

Essener Rückenschmerzzentrum, Universitätsklinikum Essen

Essen, 45147, Germany

Location

Schmerzzentrum, Ruprechts - Karls Universität Heidelberg

Heidelberg, 69120, Germany

Location

Poliklinische Institutsambulanz für Psychotherapie

Mainz, 55122, Germany

Location

Phillips-Universität Marburg

Marburg, 35037, Germany

Location

Related Publications (13)

  • Kuntz B, Hoebel J, Fuchs J, Neuhauser H, Lampert T. [Social inequalities in the prevalence of chronic back pain among adults in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jul;60(7):783-791. doi: 10.1007/s00103-017-2568-z. German.

    PMID: 28516263BACKGROUND
  • van Tulder M, Koes B. Chronic low back pain. Am Fam Physician. 2006 Nov 1;74(9):1577-9. No abstract available.

    PMID: 17111899BACKGROUND
  • Freburger JK, Holmes GM, Agans RP, Jackman AM, Darter JD, Wallace AS, Castel LD, Kalsbeek WD, Carey TS. The rising prevalence of chronic low back pain. Arch Intern Med. 2009 Feb 9;169(3):251-8. doi: 10.1001/archinternmed.2008.543.

    PMID: 19204216BACKGROUND
  • Chenot JF, Greitemann B, Kladny B, Petzke F, Pfingsten M, Schorr SG. Non-Specific Low Back Pain. Dtsch Arztebl Int. 2017 Dec 25;114(51-52):883-890. doi: 10.3238/arztebl.2017.0883.

    PMID: 29321099BACKGROUND
  • Qaseem A, Wilt TJ, McLean RM, Forciea MA; Clinical Guidelines Committee of the American College of Physicians; Denberg TD, Barry MJ, Boyd C, Chow RD, Fitterman N, Harris RP, Humphrey LL, Vijan S. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017 Apr 4;166(7):514-530. doi: 10.7326/M16-2367. Epub 2017 Feb 14.

    PMID: 28192789BACKGROUND
  • Bernstein IA, Malik Q, Carville S, Ward S. Low back pain and sciatica: summary of NICE guidance. BMJ. 2017 Jan 6;356:i6748. doi: 10.1136/bmj.i6748. No abstract available.

    PMID: 28062522BACKGROUND
  • Eccleston C, Morley SJ, Williams AC. Psychological approaches to chronic pain management: evidence and challenges. Br J Anaesth. 2013 Jul;111(1):59-63. doi: 10.1093/bja/aet207.

    PMID: 23794646BACKGROUND
  • Kamper SJ, Apeldoorn AT, Chiarotto A, Smeets RJ, Ostelo RW, Guzman J, van Tulder MW. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. Cochrane Database Syst Rev. 2014 Sep 2;2014(9):CD000963. doi: 10.1002/14651858.CD000963.pub3.

    PMID: 25180773BACKGROUND
  • Glombiewski JA, Holzapfel S, Riecke J, Vlaeyen JWS, de Jong J, Lemmer G, Rief W. Exposure and CBT for chronic back pain: An RCT on differential efficacy and optimal length of treatment. J Consult Clin Psychol. 2018 Jun;86(6):533-545. doi: 10.1037/ccp0000298.

    PMID: 29781651BACKGROUND
  • Holzapfel S, Schemer L, Riecke J, Glombiewski JA. Behavioral Test (BAT-Back): Preliminary Evidence for a Successful Predictor of Treatment Outcome After Exposure Treatment for Chronic Low Back Pain. Clin J Pain. 2021 Apr 1;37(4):265-269. doi: 10.1097/AJP.0000000000000920.

    PMID: 33555697BACKGROUND
  • Hasenbring MI, Verbunt JA. Fear-avoidance and endurance-related responses to pain: new models of behavior and their consequences for clinical practice. Clin J Pain. 2010 Nov-Dec;26(9):747-53. doi: 10.1097/AJP.0b013e3181e104f2.

    PMID: 20664333BACKGROUND
  • de Jong JR, Vlaeyen JWS, Onghena P, Cuypers C, den Hollander M, Ruijgrok J. Reduction of pain-related fear in complex regional pain syndrome type I: the application of graded exposure in vivo. Pain. 2005 Aug;116(3):264-275. doi: 10.1016/j.pain.2005.04.019.

    PMID: 15964686BACKGROUND
  • Vogt R, Haas J, Baumann L, Sander A, Klose C, Riecke J, Rief W, Bingel U, Maser D, Witthoft M, Kessler J, Zugaj MR, Ditzen B, Glombiewski JA. EFFects of Exposure and Cognitive behavioral Therapy for chronic BACK pain ("EFFECT-BACK"): study protocol for a randomized controlled trial. Trials. 2024 Mar 11;25(1):176. doi: 10.1186/s13063-024-08017-9.

MeSH Terms

Interventions

Implosive TherapyCognitive Behavioral Therapy

Intervention Hierarchy (Ancestors)

Desensitization, PsychologicBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Julia A Glombiewski, Prof. Dr.

    RPTU Kaiserslautern - Landau, Department of Clinical Psychology and Psychotherapy

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a prospective, multicentre, randomised, controlled, open-label, two-arm intervention study with a parallel group design. Two parallel groups are formed, the intervention group receives 10 sessions of EXP therapy, the control group receives 10 sessions of CBT. The assignment to the therapy methods is randomised. This is a multicentre study, the study will be conducted at 5 centres throughout Germany. A total of 380 patients will be included. Per study arm, 190 patients must be included.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2022

First Posted

March 24, 2022

Study Start

March 1, 2022

Primary Completion

October 31, 2025

Study Completion (Estimated)

October 31, 2027

Last Updated

May 20, 2025

Record last verified: 2025-05

Locations